FDA gives greenlight for new treatment of head and neck cancer (News-Medical-Net)
The U.S. Food and Drug Administration has approved colon cancer drug Erbitux to treat head and neck cancer after results of a large clinical trial showed the drug prolonged survival by 20 months.